Kingyork

Kingyork, officially known as Tianjin Kingyork Group, is a leading Chinese pharmaceutical company specializing in the development and manufacture of corticosteroid drugs. Headquartered in Tianjin, the company is recognized as one of the world's largest production bases for steroid hormones, including dexamethasone and prednisone. Its operations span the entire pharmaceutical value chain, from the fermentation and synthesis of active pharmaceutical ingredients (APIs) to the production of finished dosages such as injections, tablets, and ointments. Kingyork's extensive product portfolio also includes amino acid infusions and cardiovascular medications, serving both domestic and international markets in over 70 countries. As a core subsidiary of the Tianjin Pharmaceutical Group, Kingyork maintains high standards of quality with multiple GMP-certified facilities and a strong focus on industrial-scale hormone production.